Abstract
Background
Oral calcium and calcitriol are often prescribed after total thyroidectomy to avoid biochemical and/or symptomatic hypocalcemia. We aimed to identify independent perioperative factors that correlated with the duration of calcium and/or calcitriol supplementation after total thyroidectomy.
Methods
Of 271 eligible patients, 48 (17.7 %) required calcium and/or calcitriol supplements on discharge. Patients were gradually weaned from the supplementation by one surgeon according to a biweekly algorithm based on serum calcium (Ca). Duration of supplementation was calculated from the date of operation to the date of ceasing all supplementation without biochemical hypocalcemia (i.e., serum adjusted Ca ≥8.44 mg/dL). The Cox regression analysis was performed to identify independent perioperative factors for duration of supplementation. The best cut-off value for these independent factors was determined by the receiver characteristic curve.
Results
In the multivariate analysis, parathyroid hormone (PTH) at skin closure (PTH-SC) (RR 1.742, 95 % CI 1.080–2.810) and on postoperative day 1 adjusted Ca (Ca-D1) (RR 77.526, 95 % CI 3.600–1669.57) were the only two independent determinants for shorter duration before ceasing all supplementation. The best cut-off values in predicting supplementation ≥6 months for PTH-SC and Ca-D1 were 7.08 pg/mL (sensitivity = 100 %, specificity = 60.5 %, PPV = 40.0 % and NPV = 100 %) and 7.88 mg/dL (sensitivity = 90.0 %, specificity = 55.3 %, PPV = 34.6 % and NPV = 95.5 %), respectively.
Conclusions
Both PTH-SC and Ca-D1 were independently associated with the duration of supplementation after total thyroidectomy. Almost all patients with PTH-SC ≥7.08 pg/mL or Ca-D1 ≥7.88 mg/dL did not require supplementation ≥6 months whereas about one third of patients with PTH-SC <7.08 pg/mL or Ca-D1 <7.88 mg/dL required supplementation ≥6 months.
Similar content being viewed by others
References
Wong KP, Lang BH (2011) Graves’ ophthalmopathy as an indication increased the risk of hypoparathyroidism after bilateral thyroidectomy. World J Surg 35:2212–2218. doi:10.1007/s00268-011-1236-y
Landry CS, Grubbs EG, Hernandez M et al (2012) Predictable criteria for selective, rather than routine, calcium supplementation following thyroidectomy. Arch Surg 147:338–344
Wang TS, Cheung K, Roman SA et al (2011) To supplement or not to supplement: a cost-utility analysis of calcium and vitamin D repletion in patients after thyroidectomy. Ann Surg Oncol 18:1293–1299
Bellantone R, Lombardi CP, Raffaelli M et al (2002) Is routine supplementation therapy (calcium and vitamin D) useful after total thyroidectomy? Surgery 132:1109–1113
Lang BH, Yih PC, Ng KK (2012) A prospective evaluation of quick intraoperative parathyroid hormone assay at the time of skin closure in predicting clinically relevant hypocalcemia after thyroidectomy. World J Surg 36:1300–1306. doi:10.1007/s00268-012-1561-9
Noordzij JP, Lee SL, Bernet VJ et al (2007) Early prediction of hypocalcemia after thyroidectomy using parathyroid hormone: an analysis of pooled individual patient data from nine observational studies. J Am Coll Surg 205:748–754
Lombardi CP, Raffaelli M, Princi P et al (2004) Early prediction of postthyroidectomy hypocalcemia by one single iPTH measurement. Surgery 136:1236–1241
Raffaelli M, De Crea C, Carrozza C et al (2012) Combining early postoperative parathyroid hormone and serum calcium levels allows for an efficacious selective post-thyroidectomy supplementation treatment. World J Surg 36:1307–1313. doi:10.1007/s00268-012-1556-6
Youngwirth L, Benavidez J, Sippel R et al (2010) Postoperative parathyroid hormone testing decreases symptomatic hypocalcemia and associated emergency room visits after total thyroidectomy. Surgery 148:841–844 discussion 844–846
Wiseman JE, Mossanen M, Ituarte PH et al (2010) An algorithm informed by the parathyroid hormone level reduces hypocalcemic complications of thyroidectomy. World J Surg 34:532–537. doi:10.1007/s00268-009-0348-0
Yano Y, Nagahama M, Sugino K et al (2008) Long-term changes in parathyroid function after subtotal thyroidectomy for Graves’ disease. World J Surg 32:2612–2616. doi:10.1007/s00268-008-9754-y
Youngwirth L, Benavidez J, Sippel R et al (2010) Parathyroid hormone deficiency after total thyroidectomy: incidence and time. J Surg Res 163:69–71
Hermann M, Ott J, Promberger R et al (2008) Kinetics of serum parathyroid hormone during and after thyroid surgery. Br J Surg 95:1480–1487
Wang TS, Cayo AK, Wilson SD et al (2011) The value of postoperative parathyroid hormone levels in predicting the need for long-term vitamin D supplementation after total thyroidectomy. Ann Surg Oncol 18:777–781
Wong IO, Chan WS, Choi S et al (2006) Moral hazard or realised access to care? Empirical observation in Hong Kong. Health Policy 75:251–261
Lang BH, Lo CY (2005) Total thyroidectomy for multinodular goiter in the elderly. Am J Surg 190:418–423
Erbil Y, Bozbora A, Ozbey N et al (2007) Predictive value of age and serum parathormone and vitamin d3 levels for postoperative hypocalcemia after total thyroidectomy for nontoxic multinodular goiter. Arch Surg 142:1182–1187
AES Guidelines 06/01 Group (2007) Australian Endocrine Surgeons Guidelines AES06/01. Postoperative parathyroid hormone measurement and early discharge after total thyroidectomy: analysis of Australian data and management recommendations. ANZ J Surg 77:199–202
Lo CY, Lam KY (1998) Postoperative hypocalcemia in patients who did or did not undergo parathyroid autotransplantation during thyroidectomy: a comparative study. Surgery 124:1081–1086 discussion 1086–1087
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Lang, B.HH., Wong, K.P. How Useful Are Perioperative Biochemical Parameters in Predicting the Duration of Calcium and/or Vitamin D Supplementation After Total Thyroidectomy?. World J Surg 37, 2581–2588 (2013). https://doi.org/10.1007/s00268-013-2195-2
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00268-013-2195-2